Articles that mention Sanofi -BoardProspects

Sanofi

0 Comments Leave a Comment

1-15 of 19 1 2 »
1. Mentioned In 19 Articles
2. Ready to Rumble, Ironwood? Activist Investor Alex Denner Suits up for Board-Seat Bid
  
  Explore Pharma News Apr 10 2018 BoardNews
  
  ...opharma companies over the last few years, including Ariad and Aegerion. Most recently, he helped orchestrate Sanofi’s $11.6 billion Bioverativ buy, which redeemed the French drugmaker after failed plays for Medivation a...
  Read Full Article
  
  Comment
  
  Mentions: Management IPO Wells Fargo
3. Activist Alex Denner to Gain Board Control at Medicines Company
  
  Explore CNBC.com Mar 1 2018 BoardNews
  
  ...red with Sanofi. Early sales have disappointed, though some key data are expected this month on Regeneron and Sanofi's drug, Praluent, that investors hope could spur sales. Inclisiran is designed to have to be injected l...
  Read Full Article
  
  Comment
  
  Mentions: CEO Sanofi Carl Icahn
4. L’Oreal CEO Says Cosmetics Maker Ready to Buy Nestle's Stake - Bloomberg
  
  Explore Bloomberg Feb 9 2018 BoardNews
  
  ... L’Oreal’s founding family, in September. L’Oreal has 1.8 billion euros in cash and owns a 9 percent stake in Sanofi. “If it was not enough, we got love letters from lots of great banks telling us they would love to lend...
  Read Full Article
  
  Comment
  
  Mentions: Investors CEO Sanofi
5. Sanofi is Buying Another Blood-Disease Biotech for $4.8 Billion
  
  Explore Business Insider Jan 29 2018 BoardNews
  
  ...would boost long-term value for its shareholders, while the takeover was expected to have a neutral impact on Sanofi's business earnings per share (EPS) in 2018 and 2019. Sanofi is already one of Ablynx's big pharma part...
  Read Full Article
  
  Comment
  
  Mentions: Sanofi acquisition Morgan Stanley
6. ImmunoGen Appoints Stuart A. Arbuckle to Board of Directors
  
  Explore businesswire.com Jan 24 2018 BoardMoves
  
  ...duct, Kadcyla®, and in programs in development by Amgen, Bayer, Biotest, CytomX, Debiopharm, Lilly, Novartis, Sanofi and Takeda. More information about the Company can be found at www.immunogen.com. Kalydeco®, Orkambi®, ...
  Read Full Article
  
  Comment
  
  Mentions: Investors Sanofi Nasdaq
7. Acerus Appoints Mr. Mark Lievonen to its Board of Directors
  
  Explore businesswire.com Dec 7 2017 BoardMoves
  
  ...ceutical industry, more recently as the President of Sanofi Pasteur Limited, the Canadian vaccine division of Sanofi, a global pharmaceutical company. He is a Director of Oncolytics Biotech Inc., Quest PharmaTech Inc., a...
  Read Full Article
  
  Comment
  
  Mentions: Audit Committee Sanofi Twitter
8. PerkinElmer Elects Pascale Witz to its Board of Directors
  
  Explore businesswire.com Oct 30 2017 BoardMoves
  
  ...st recently serving as executive vice president, Global Diabetes and Cardiovascular for Sanofi, S.A. Prior to Sanofi, she held several leadership positions during her 17 years with GE Healthcare, including the role of pr...
  Read Full Article
  
  Comment
  
  Mentions: CEO Sanofi MBA
9. L'Oreal Advances on Prospect of Sale of Nestle's Holding
  
  Explore Bloomberg Sep 22 2017 BoardNews
  
  ...not the right time to make any further comment.” L’Oreal could sell its 9.4 percent stake in French drugmaker Sanofi to finance a repurchase of Nestle’s stake, according to Pierre Tegner, an analyst at Natixis. A judge i...
  Read Full Article
  
  Comment
  
  Mentions: Sanofi Takeover Sale
10. Nestle: Overseas Activism Has Overhangs
  
  Explore Stock Market News & Financial Analysis Jun 29 2017 BoardNews
  
  ...t would take some work for L'Oreal, but there are options - raising debt, using cash and possibly selling its Sanofi stake. The move would be a positive for Nestle, providing cash for buybacks and acquisitions, as well b...
  Read Full Article
  
  Comment
  
  Mentions: Corporate Governance Investors CEO
11. How Third Point's Nestlé Assault Makes L'Oréal Worth It
  
  Explore Home Jun 27 2017 BoardBlogs
  
  ... pledged to do, it would have almost €10bn of firepower. It could add €10bn by selling its stake in drugmaker Sanofi. Buying and cancelling the shares would add about 15 per cent to L'Oréal's earnings per share, says RBC...
  Read Full Article
  
  Comment
  
  Mentions: Activist Investors Hedge Fund Sanofi
12. Regulus Therapeutics (RGLS) Names Pascale Witz to Board of Directors
  
  Explore StreetInsider.com Jun 1 2017 BoardMoves
  
  ...aving served most recently as Executive Vice President, Diabetes and Cardiovascular for Sanofi, S.A. Prior to Sanofi, Ms. Witz held positions of increasing responsibility with GE Healthcare, most recently serving as the ...
  Read Full Article
  
  Comment
  
  Mentions: CEO Annual Meeting Sanofi
13. Sarepta CEO Exits Along With a Sanofi Director, So Let's Speculate About a Possible Deal
  
  Explore Stock Market Today Apr 29 2017 BoardBlogs
  
  ...and mean nothing, or they might signal Sanofi's interest in acquiring Sarepta. There is no outward evidence a Sanofi-Sarepta deal is in the works. I'm going to repeat that sentence. There is no outward evidence a Sanofi-...
  Read Full Article
  
  Comment
  
  Mentions: Mergers and Acquisitions Sanofi
14. Warp Drive Bio Appoints Rachel K. King to Its Board of Directors
  
  Explore cbs8.com Jul 5 2016 BoardMoves
  
  ...nificant difference in patients’ lives. The company was launched in 2012 through a strategic partnership with Sanofi and with financing from Third Rock Ventures and Greylock Partners. For more information, please visit w...
  Read Full Article
  
  Comment
  
  Mentions: Leadership Sanofi Board of Directors
15. Sanofi Inc. Nominates Eight New Board Members
  
  Explore CNBC.com May 13 2016 BoardNews
  
  ...replace the board at any time..... This story is developing. Please check back for further updates. Drugmaker Sanofi will nominate 8 people to replace the board of biotechnology company Medivation, sources told CNBC Frid...
  Read Full Article
  
  Comment
  
  Mentions: Sanofi Board of Directors
16. BIO's Jim Greenwood will Chair BVGH's Board of Directors.
  
  Explore news.thomasnet.com Mar 23 2016 BoardMoves
  
  ...llaborations by end of 2015. Takeda and Johnson & Johnson recently joined Pfizer, Novartis, GSK, Merck (MSD), Sanofi, Alnylam, Eisai, and Merck KGaA in contributing their resources to advance neglected tropical disease r...
  Read Full Article
  
  Comment
  
  Mentions: Board Chair CEO Annual Meeting
17. 1-15 of 19 1 2 »